Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.10. | Bolt Projects Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
26.09. | Bolt Projects registers 20M shares for potential sale under $20M equity line | 2 | Seeking Alpha | ||
26.09. | Bolt Projects Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
15.09. | Bolt Projects Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
29.08. | Bolt Projects Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
22.08. | Bolt Projects files to sell 913,979 shares of common stock for holders | 1 | Seeking Alpha | ||
BOLT PROJECTS Aktie jetzt für 0€ handeln | |||||
22.08. | Bolt Projects Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
15.08. | Bolt Projects to raise $4.25M in private placement | 5 | Seeking Alpha | ||
15.08. | Bolt Projects announces $4.25 million private placement | 1 | Investing.com | ||
14.08. | Aktie von Bolt Projects bricht nach Kapitalerhöhung mit hohem Abschlag ein | 2 | Investing.com Deutsch | ||
14.08. | Bolt Projects stock tumbles after discounted share offering | 12 | Investing.com | ||
14.08. | Pre-market Movers: Sonoma Pharmaceuticals, Bolt Projects, Ibotta, TeraWulf, 180 Life Sciences | 616 | AFX News | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.50 A.M. ET).In the Green Sonoma Pharmaceuticals, Inc. (SNOA) is up over... ► Artikel lesen | |
14.08. | Bolt Projects Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
14.08. | Bolt Projects Holdings Stock Plunges Over 25% In Pre-Market Trading, Day After 557% Surge | 1 | Benzinga.com | ||
13.08. | Bolt Projects Stock Surges 38% on Strong Q2, $20M Funding; CEO: 'Demand For Vegan Silk Continues To Grow' | 15 | Benzinga.com | ||
12.08. | Bolt Projects Holdings, Inc. - 10-Q, Quarterly Report | 11 | SEC Filings | ||
06.08. | Bolt Projects Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
17.07. | HotStocks USA: +102 % bei Bolt Projects | 13 | stock3.com | ||
17.07. | Pre-market Movers: Volcon, Bolt Projects, 22nd Century Group, Above Food Ingredients, Windtree Therapeutics | 777 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.25 A.M. ET).In the Green Volcon, Inc. (VLCN) is up over 161% at $24.11.
Bolt... ► Artikel lesen | |
14.07. | Bolt Projects Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EVOTEC | 6,836 | +0,86 % | Evotec-Aktie mit leichten Kursgewinnen (6,248 €) | Die Aktie von Evotec notiert am Mittwoch fester. Zuletzt zahlten Investoren für die Aktie 6,25 Euro. An der Börse liegt das Wertpapier von Evotec zur Stunde im Plus. Das Wertpapier legte um 6 Cent zu.... ► Artikel lesen | |
QIAGEN | 40,765 | +1,52 % | Sysmex, QIAGEN Announce Exclusive Distribution Partnership For Diagnostic Products In Japan | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) and QIAGEN K.K., the Japanese subsidiary of QIAGEN N.V., announced on Wednesday that they have entered into a partnership for clinical diagnostic... ► Artikel lesen | |
CUREVAC | 4,636 | -0,04 % | CureVac mit SONDERMELDUNG: Könnte die Aktie jetzt komplett drehen - Profis haben bereits gehandelt! | ||
VALNEVA | 4,724 | +4,10 % | Hensoldt Aktie: "Heiße" neue Signale - Daldrup, freenet, Lufthansa, Renk und Valneva im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
NOVAVAX | 7,665 | -3,10 % | Novavax hands over Nuvaxovid marketing rights to Sanofi in the EU | ||
HEIDELBERG PHARMA | 3,080 | -1,91 % | EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma gibt Aktualisierung der Prognose bekannt | EQS-Ad-hoc: Heidelberg Pharma AG / Schlagwort(e): Prognoseänderung
Heidelberg Pharma AG gibt Aktualisierung der Prognose bekannt
06.10.2025 / 15:58 CET/CEST
Veröffentlichung einer... ► Artikel lesen | |
CRISPR THERAPEUTICS | 67,00 | +9,84 % | CRISPR Therapeutics AG: CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress | ||
VIVOSIM LABS | 1,220 | -100,00 % | VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer | SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing... ► Artikel lesen | |
OCUGEN | 1,547 | +2,11 % | Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea | Upfront fees and near-term development milestone payments totaling up to $7.5 millionPotential sales milestones of $180 million or more in first 10 years of commercializationRoyalties equaling 25%... ► Artikel lesen | |
MAINZ BIOMED | 1,640 | 0,00 % | EQS-News: Mainz BioMed N.V.: Mainz Biomed berichtet Topline-Ergebnisse aus der Machbarkeitsstudie zum Biomarker-Panel im Rahmen seines Bauchspeicheldrüsenkrebs-Projekts | Emittent / Herausgeber: Mainz BioMed N.V.
/ Schlagwort(e): Studienergebnisse
Mainz Biomed berichtet Topline-Ergebnisse aus der Machbarkeitsstudie zum Biomarker-Panel im Rahmen... ► Artikel lesen | |
INFLARX | 1,258 | +4,66 % | InflaRx N.V.: InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement | JENA, Germany, Sept. 12, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the "Company")... ► Artikel lesen | |
INTELLIA THERAPEUTICS | 21,020 | +19,77 % | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies... ► Artikel lesen | |
TEMPUS AI | 88,50 | +10,62 % | Why Tempus AI Stock Was Motoring Higher This Week | ||
EDITAS MEDICINE | 3,577 | +5,89 % | Editas Medicine to present CRISPR cholesterol research at ESGCT | ||
VIVORYON THERAPEUTICS | 1,630 | +0,37 % | Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE... ► Artikel lesen |